Geron CorporationGERNNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor GERN?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor GERN

Key Statistics

About

we are a biopharmaceutical company developing first-in-class therapies for cancer. imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

John Scarlett

geron.com/ →

Alerts

Key Statistics

About

News

Gold prices holding support at $4,700 as ISM Manufacturing PMI sees sharp increase

Buy These 5 Dividend Growth Stocks Amid Fed Policy Uncertainty

Can Cannabis Strength in Canada Drive Canopy's Q3 Earnings?

Entergy's Grid and Renewable Investments Strengthen Growth Outlook

Linde Set to Report Q4 Earnings: What's in Store for the Stock?

Unlocking V.F. (VFC) International Revenues: Trends, Surprises, and Prospects

Exploring Analyst Estimates for Lightspeed POS (LSPD) Q3 Earnings, Beyond Revenue and EPS

The New York Times Company (NYT) Hit a 52 Week High, Can the Run Continue?

Avnet, Inc. (AVT) Hit a 52 Week High, Can the Run Continue?

American Public Education, Inc. (APEI) Hits Fresh High: Is There Still Room to Run?

Hologic (HOLX) International Revenue Performance Explored

Curious about Affirm Holdings (AFRM) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Archrock, Inc. (AROC) Hit a 52 Week High, Can the Run Continue?

Curious about Rithm (RITM) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Unlocking IBM (IBM) International Revenues: Trends, Surprises, and Prospects

Curious about Cummins (CMI) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Moog Inc. (MOG.A) Hit a 52 Week High, Can the Run Continue?

Don't Overlook Avnet (AVT) International Revenue Trends While Assessing the Stock

Unlocking Applied Industrial Technologies (AIT) International Revenues: Trends, Surprises, and Prospects

Gear Up for Fortinet (FTNT) Q4 Earnings: Wall Street Estimates for Key Metrics

Explore More

Gold prices holding support at $4,700 as ISM Manufacturing PMI sees sharp increase

Buy These 5 Dividend Growth Stocks Amid Fed Policy Uncertainty

Can Cannabis Strength in Canada Drive Canopy's Q3 Earnings?

Entergy's Grid and Renewable Investments Strengthen Growth Outlook

Linde Set to Report Q4 Earnings: What's in Store for the Stock?

Unlocking V.F. (VFC) International Revenues: Trends, Surprises, and Prospects

Exploring Analyst Estimates for Lightspeed POS (LSPD) Q3 Earnings, Beyond Revenue and EPS

The New York Times Company (NYT) Hit a 52 Week High, Can the Run Continue?

Avnet, Inc. (AVT) Hit a 52 Week High, Can the Run Continue?

American Public Education, Inc. (APEI) Hits Fresh High: Is There Still Room to Run?

Hologic (HOLX) International Revenue Performance Explored

Curious about Affirm Holdings (AFRM) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Archrock, Inc. (AROC) Hit a 52 Week High, Can the Run Continue?

Curious about Rithm (RITM) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Unlocking IBM (IBM) International Revenues: Trends, Surprises, and Prospects

Curious about Cummins (CMI) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Moog Inc. (MOG.A) Hit a 52 Week High, Can the Run Continue?

Don't Overlook Avnet (AVT) International Revenue Trends While Assessing the Stock

Unlocking Applied Industrial Technologies (AIT) International Revenues: Trends, Surprises, and Prospects

Gear Up for Fortinet (FTNT) Q4 Earnings: Wall Street Estimates for Key Metrics

Key Statistics